Switch to:
Novo Nordisk A/S (NYSE:NVO)
EV/EBITDA
19.37 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Novo Nordisk A/S's enterprise value is $119,214 Mil. Novo Nordisk A/S's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $6,153 Mil. Therefore, Novo Nordisk A/S's EV/EBITDA ratio for today is 19.37.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Novo Nordisk A/S's stock price is $44.19. Novo Nordisk A/S's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $1.78. Therefore, Novo Nordisk A/S's P/E Ratio for today is 24.83.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Novo Nordisk A/S's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=119213.516/6153.05936893
=19.37

Novo Nordisk A/S's current Enterprise Value is $119,214 Mil.
Novo Nordisk A/S's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was 1352.26019846 (Dec. 2013 ) + 1596.7024824 (Mar. 2014 ) + 1664.02362334 (Jun. 2014 ) + 1540.07306474 (Sep. 2014 ) = $6,153 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Novo Nordisk A/S's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=44.19/1.77980831739
=24.83

Novo Nordisk A/S's share price for today is $44.19.
Novo Nordisk A/S's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was 0.417126056597 (Dec. 2013 ) + 0.450166728418 (Mar. 2014 ) + 0.484861741492 (Jun. 2014 ) + 0.427653790882 (Sep. 2014 ) = $1.78.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda 12.3712.6614.7618.6312.6410.4513.5717.8014.1515.82

Novo Nordisk A/S Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda 17.5314.8814.1513.7712.5514.9015.8220.2320.3521.51
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK